|
Marcia - it did show ER/PR status too....age, ER/PR, # of nodes, age, and size of primary tumor. I think that was it. It showed the delta in the hazard ratio. The key takeaway is that ALL groups benefited, but to see if some were better than others, we need a "hazard ratio" interpretation.
Maybe I'll do some research!
Michelle - I do know what p values and T scores are from graduate stats class. Essentially they help you determine the probability, in this case, that the decrease in recurrance and increase in survival is due to herceptin, vs. another outside factor. Anything less than .02 is good. In the first presentation, he said that the p ratio was so small that it had as many 0's as the world poputation!! So--> .00000000001 or something like that (to the negative 12th power). That virtually guarantees that the results we saw were due to herceptin.
|